← feed

Is NCT03174795 results overdue?

Yes — results are overdue. Primary completion was 2017-12-04; the FDAAA-801 reporting deadline (2018-12-04) passed 2756 days ago and no results are posted on ClinicalTrials.gov.

A Study to Investigate the Pharmacokinetics of RO7079901 and Meropenem in Participants With a Complicated Urinary Tract Infection

NCT IDNCT03174795 ↗
SponsorHoffmann-La Roche (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2017-12-04 (ACTUAL)
Reporting deadline2018-12-04 (completion + 365d)
Days overdue2756
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 1de869dd3a42a6a1… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03174795. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →